{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T06:14:13Z","timestamp":1772691253569,"version":"3.50.1"},"reference-count":78,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["IIP-1713953"],"award-info":[{"award-number":["IIP-1713953"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["CBET-1264336"],"award-info":[{"award-number":["CBET-1264336"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biotechnology Advances"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.biotechadv.2018.03.017","type":"journal-article","created":{"date-parts":[[2018,3,26]],"date-time":"2018-03-26T12:28:38Z","timestamp":1522067318000},"page":"1185-1193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Clinical, technological, and economic issues associated with developing new lung surfactant therapeutics"],"prefix":"10.1016","volume":"36","author":[{"given":"Hyun Chang","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8347-6375","authenticated-orcid":false,"given":"You-Yeon","family":"Won","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.biotechadv.2018.03.017_bb0005","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/00003246-200107000-00002","article-title":"Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care","volume":"29","author":"Angus","year":"2001","journal-title":"Crit. Care Med."},{"issue":"6","key":"10.1016\/j.biotechadv.2018.03.017_bb0010","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1651-2227.2005.tb01984.x","article-title":"A randomized trial comparing beractant and poractant treatment in neonatal respiratory distress syndrome","volume":"94","author":"Ann Malloy","year":"2005","journal-title":"Acta Paediatr."},{"issue":"22","key":"10.1016\/j.biotechadv.2018.03.017_bb0015","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJM199605303342201","article-title":"Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome","volume":"334","author":"Anzueto","year":"1996","journal-title":"N. Engl. J. Med."},{"issue":"5, Part 1","key":"10.1016\/j.biotechadv.2018.03.017_bb0020","first-page":"517","article-title":"Surface properties in relation to atelectasis and hyaline membrane disease","volume":"97","author":"Avery","year":"1959","journal-title":"A.M.A. J. Dis. Children"},{"issue":"9","key":"10.1016\/j.biotechadv.2018.03.017_bb0025","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJMp048172","article-title":"Exogenous surfactant replacement in ARDS \u2014 one day, someday, or never?","volume":"351","author":"Baudouin","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.biotechadv.2018.03.017_bb0030","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1542\/peds.100.1.31","article-title":"Comparison of Infasurf (calf lung surfactant extract) to Survanta (Beractant) in the treatment and Prevention of respiratory distress syndrome","volume":"100","author":"Bloom","year":"1997","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.biotechadv.2018.03.017_bb0035","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2009-0126","article-title":"Dosing of porcine surfactant: effect on kinetics and gas exchange in respiratory distress syndrome","volume":"124","author":"Cogo","year":"2009","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.biotechadv.2018.03.017_bb0040","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/0002-9378(95)90222-8","article-title":"Antenatal corticosteroid therapy: a meta-analysis of the randomized trials, 1972 to 1994","volume":"173","author":"Crowley","year":"1995","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.biotechadv.2018.03.017_bb0045","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1542\/peds.51.4.629","article-title":"Artificial ventilation in hyaline membrane disease: the use of positive end-expiratory pressure and continuous positive airway pressure","volume":"51","author":"Cumarasamy","year":"1973","journal-title":"Pediatrics"},{"key":"10.1016\/j.biotechadv.2018.03.017_bb0050","author":"Curosurf.com"},{"issue":"5","key":"10.1016\/j.biotechadv.2018.03.017_bb0060","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1542\/peds.2005-2215","article-title":"The epidemiology of meconium aspiration syndrome: incidence, risk factors, therapies, and outcome","volume":"117","author":"Dargaville","year":"2006","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.biotechadv.2018.03.017_bb0065","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1517\/14656566.9.3.475","article-title":"Aerosolized lucinactant: a potential alternative to intratracheal surfactant replacement therapy","volume":"9","author":"Donn","year":"2008","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.biotechadv.2018.03.017_bb0070","series-title":"Manual of Neonatal Respiratory Care","author":"Donn","year":"2016"},{"issue":"30","key":"10.1016\/j.biotechadv.2018.03.017_bb0075","doi-asserted-by":"crossref","first-page":"9287","DOI":"10.1073\/pnas.1504025112","article-title":"Three-dimensional model of surfactant replacement therapy","volume":"112","author":"Filoche","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.biotechadv.2018.03.017_bb0080","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1542\/peds.97.1.48","article-title":"Surfactant replacement therapy for meconium aspiration syndrome","volume":"97","author":"Findlay","year":"1996","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.biotechadv.2018.03.017_bb0085","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1089\/jamp.2009.0758","article-title":"An open label, pilot study of Aerosurf(R) combined with nCPAP to prevent RDS in preterm neonates","volume":"23","author":"Finer","year":"2010","journal-title":"J. Aerosol Med. Pulmonary Drug Deliv."},{"issue":"2","key":"10.1016\/j.biotechadv.2018.03.017_bb0090","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/14787210.2017.1259067","article-title":"Anti-inflammatory effects of the new generation synthetic surfactant CHF5633 on Ureaplasma-induced cytokine responses in human monocytes","volume":"15","author":"Glaser","year":"2017","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"10.1016\/j.biotechadv.2018.03.017_bb0095","series-title":"Avery's Diseases of the Newborn E-Book","author":"Gleason","year":"2011"},{"issue":"4","key":"10.1016\/j.biotechadv.2018.03.017_bb0100","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1164\/ajrccm.155.4.9105072","article-title":"Bovine surfactant therapy for patients with acute respiratory distress syndrome","volume":"155","author":"Gregory","year":"1997","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.biotechadv.2018.03.017_bb0105","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1164\/ajrccm.152.3.7663782","article-title":"Pharmacokinetics of bovine surfactant in neonatal respiratory distress syndrome","volume":"152","author":"Griese","year":"1995","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.biotechadv.2018.03.017_bb0110","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1164\/rccm.201607-1401LE","article-title":"Did reduced alveolar delivery of surfactant contribute to negative results in adults with acute respiratory distress syndrome?","volume":"195","author":"Grotberg","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.biotechadv.2018.03.017_bb0115","first-page":"220","article-title":"A pharmacoeconomic analysis of in-hospital costs resulting from reintubation in preterm infants treated with Lucinactant, Beractant, or Poractant alfa","volume":"17","author":"Guardia","year":"2012","journal-title":"JPPT"},{"issue":"1","key":"10.1016\/j.biotechadv.2018.03.017_bb0120","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1152\/jappl.1998.85.1.333","article-title":"A theoretical study of surfactant and liquid delivery into the lung","volume":"85","author":"Halpern","year":"1998","journal-title":"J. Appl. Physiol."},{"issue":"3","key":"10.1016\/j.biotechadv.2018.03.017_bb0125","first-page":"1","article-title":"Births: preliminary data for 2015","volume":"65","author":"Hamilton","year":"2016","journal-title":"Natl Vital Stat Rep"},{"issue":"2 Pt 1","key":"10.1016\/j.biotechadv.2018.03.017_bb0130","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1164\/ajrccm.151.2.7842182","article-title":"Clinical risks for development of the acute respiratory distress syndrome","volume":"151","author":"Hudson","year":"1995","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.biotechadv.2018.03.017_bb0135","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/pr.2015.165","article-title":"Nebulization of Poractant alfa via a vibrating membrane nebulizer in spontaneously breathing preterm lambs with binasal continuous positive pressure ventilation","volume":"78","author":"Hutten","year":"2015","journal-title":"Pediatr. Res."},{"issue":"2","key":"10.1016\/j.biotechadv.2018.03.017_bb0140","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3349\/ymj.2015.56.2.433","article-title":"Efficacy of surfactant-TA, Calfactant and Poractant alfa for preterm infants with respiratory distress syndrome: a retrospective study","volume":"56","author":"Jeon","year":"2015","journal-title":"Yonsei Med. J."},{"issue":"2","key":"10.1016\/j.biotechadv.2018.03.017_bb0145","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jpeds.2012.07.013","article-title":"The cost of morbidities in very low birth weight infants","volume":"162","author":"Johnson","year":"2013","journal-title":"J. Pediatr."},{"issue":"10","key":"10.1016\/j.biotechadv.2018.03.017_bb0150","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1164\/rccm.200812-1955OC","article-title":"Exogenous natural surfactant for treatment of acute lung injury and the acute respiratory distress syndrome","volume":"180","author":"Kesecioglu","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.biotechadv.2018.03.017_bb0155","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1542\/peds.92.1.135","article-title":"Surfactant therapy in full-term neonates with severe respiratory failure","volume":"92","author":"Khammash","year":"1993","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.biotechadv.2018.03.017_bb0160","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1096\/fj.00-0318rev","article-title":"Surfactant protein A (SP-A): the alveolus and beyond","volume":"15","author":"Khubchandani","year":"2001","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.biotechadv.2018.03.017_bb0165","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.coph.2006.02.003","article-title":"In defense of the lung: surfactant protein A and surfactant protein D","volume":"6","author":"Kingma","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"issue":"1","key":"10.1016\/j.biotechadv.2018.03.017_bb0170","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/BF00442605","article-title":"Surfactant replacement therapy in neonatal respiratory distress syndrome","volume":"147","author":"Konishi","year":"1988","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.biotechadv.2018.03.017_bb0175","series-title":"Surfactant Replacement Therapy: In Neonatal and Adult Respiratory Distress Syndrome","author":"Lachmann","year":"1989"},{"key":"10.1016\/j.biotechadv.2018.03.017_bb0180","doi-asserted-by":"crossref","DOI":"10.1177\/2333794X17696683","article-title":"Less invasive surfactant administration reduces the need for mechanical ventilation in preterm infants","volume":"4","author":"Lau","year":"2017","journal-title":"Global Pediatric Health"},{"issue":"4","key":"10.1016\/j.biotechadv.2018.03.017_bb0185","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1542\/peds.50.4.515","article-title":"A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants","volume":"50","author":"Liggins","year":"1972","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.biotechadv.2018.03.017_bb0190","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0022-3476(98)70482-2","article-title":"Multicenter study of surfactant (beractant) use in the treatment of term infants with severe respiratory failure","volume":"132","author":"Lotze","year":"1998","journal-title":"J. Pediatr."},{"issue":"3","key":"10.1016\/j.biotechadv.2018.03.017_bb0195","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00130478-200207000-00011","article-title":"Multicenter, randomized, controlled study of porcine surfactant in severe respiratory syncytial virus-induced respiratory failure*","volume":"3","author":"Luchetti","year":"2002","journal-title":"Pediatr. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.biotechadv.2018.03.017_bb0200","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nrd.2017.70","article-title":"How much do clinical trials cost?","volume":"16","author":"Martin","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.biotechadv.2018.03.017_bb0205","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00134-003-1650-1","article-title":"Treatment with bovine surfactant in severe acute respiratory distress syndrome in children: a randomized multicenter study","volume":"29","author":"M\u00f6ller","year":"2003","journal-title":"Intensive Care Med."},{"issue":"1","key":"10.1016\/j.biotechadv.2018.03.017_bb0210","first-page":"1","article-title":"Randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome","volume":"97","author":"Multicenter","year":"1996","journal-title":"Pediatrics"},{"key":"10.1016\/j.biotechadv.2018.03.017_bb0215","series-title":"Lung Surfactant Function and Disorder","author":"Nag","year":"2005"},{"issue":"Suppl. C","key":"10.1016\/j.biotechadv.2018.03.017_bb0220","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.conctc.2016.04.003","article-title":"Comparison of efficacy and safety of two available natural surfactants in Iran, Curosurf and Survanta in treatment of neonatal respiratory distress syndrome: a randomized clinical trial","volume":"3","author":"Najafian","year":"2016","journal-title":"Contemp. Clin. Trials Commun."},{"issue":"1","key":"10.1016\/j.biotechadv.2018.03.017_bb0225","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/01.TA.0000056159.65396.7C","article-title":"A resource-based assessment of trauma care in the United States","volume":"56","author":"Nathens","year":"2004","journal-title":"J. Trauma"},{"key":"10.1016\/j.biotechadv.2018.03.017_bb0230","series-title":"Overview of the United States Cattle Industry","author":"National Agricultrual Statistics Service (NASS)","year":"2016"},{"key":"10.1016\/j.biotechadv.2018.03.017_bb0235","series-title":"Lung Surfactants: Basic Science and Clinical Applications","author":"Notter","year":"2000"},{"key":"10.1016\/j.biotechadv.2018.03.017_bb0055","series-title":"NSF I-Corps Interviews","year":"2017"},{"issue":"1","key":"10.1016\/j.biotechadv.2018.03.017_bb0240","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1038\/s41598-018-20986-x","article-title":"Quantitative imaging of regional aerosol deposition, lung ventilation and morphology by synchrotron radiation CT","volume":"8","author":"Porra","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biotechadv.2018.03.017_bb0245","author":"Windtree Therapeutics"},{"issue":"3","key":"10.1016\/j.biotechadv.2018.03.017_bb0250","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ccc.2011.04.005","article-title":"Surfactant therapy of ALI and ARDS","volume":"27","author":"Raghavendran","year":"2011","journal-title":"Crit. Care Clin."},{"issue":"3","key":"10.1016\/j.biotechadv.2018.03.017_bb0255","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0300-9572(99)00089-1","article-title":"Derivation of a prediction rule for post-traumatic acute lung injury","volume":"42","author":"Rainer","year":"1999","journal-title":"Resuscitation"},{"issue":"03","key":"10.1016\/j.biotechadv.2018.03.017_bb0260","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1055\/s-2004-823779","article-title":"A randomized, multicenter masked comparison trial of Poractant alfa (Curosurf) versus Beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants","volume":"21","author":"Ramanathan","year":"2004","journal-title":"Amer. J. Perinatol."},{"issue":"2","key":"10.1016\/j.biotechadv.2018.03.017_bb0265","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/jp.2011.125","article-title":"Mortality in preterm infants with respiratory distress syndrome treated with poractant alfa, calfactant or beractant: a retrospective study","volume":"33","author":"Ramanathan","year":"2013","journal-title":"J. Perinatol."},{"key":"10.1016\/j.biotechadv.2018.03.017_bb0270","series-title":"Surfactant Therapy for Lung Disease","author":"Robertson","year":"1995"},{"issue":"36 Suppl","key":"10.1016\/j.biotechadv.2018.03.017_bb0275","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1038\/jp.2016.31","article-title":"Efficacy and safety of surfactant replacement therapy for preterm neonates with respiratory distress syndrome in low- and middle-income countries: a systematic review","volume":"1","author":"Sankar","year":"2016","journal-title":"J. Perinatol."},{"issue":"10","key":"10.1016\/j.biotechadv.2018.03.017_bb0280","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1164\/rccm.200912-1818OC","article-title":"Surfactant protein-D inhibits lung inflammation caused by ventilation in premature newborn lambs","volume":"181","author":"Sato","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"7","key":"10.1016\/j.biotechadv.2018.03.017_bb0285","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1183\/09031936.93.06070971","article-title":"Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations","volume":"6","author":"Seeger","year":"1993","journal-title":"Eur. Respir. J."},{"issue":"10","key":"10.1016\/j.biotechadv.2018.03.017_bb0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047631","article-title":"New surfactant with SP-B and C analogs gives survival benefit after inactivation in preterm lambs","volume":"7","author":"Seehase","year":"2012","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.biotechadv.2018.03.017_bb0295","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.mayocp.2012.07.007","article-title":"The high cost of cancer drugs and what we can do about it","volume":"87","author":"Siddiqui","year":"2012","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.biotechadv.2018.03.017_bb0300","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2466-10-25","article-title":"Spatial distribution of sequential ventilation during mechanical ventilation of the uninjured lung: an argument for cyclical airway collapse and expansion","volume":"10","author":"Sinclair","year":"2010","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.biotechadv.2018.03.017_bb0305","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000510","article-title":"Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants","volume":"2","author":"Soll","year":"2001","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.biotechadv.2018.03.017_bb0310","doi-asserted-by":"crossref","first-page":"F8","DOI":"10.1136\/fn.72.1.F8","article-title":"Randomised clinical trial of two treatment regimens of natural surfactant preparations in neonatal respiratory distress syndrome","volume":"72","author":"Speer","year":"1995","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"issue":"9","key":"10.1016\/j.biotechadv.2018.03.017_bb0315","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1056\/NEJMoa033181","article-title":"Effect of recombinant surfactant protein C\u2013based surfactant on the acute respiratory distress syndrome","volume":"351","author":"Spragg","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.biotechadv.2018.03.017_bb0320","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1164\/rccm.201009-1424OC","article-title":"Recombinant surfactant protein C-based surfactant for patients with severe direct lung injury","volume":"183","author":"Spragg","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"8","key":"10.1016\/j.biotechadv.2018.03.017_bb0325","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1055\/s-0028-1085066","article-title":"The probability of neonatal respiratory distress syndrome as a function of gestational age and lecithin\/sphingomyelin ratio","volume":"25","author":"St. Clair","year":"2008","journal-title":"Am. J. Perinatol."},{"issue":"1","key":"10.1016\/j.biotechadv.2018.03.017_bb0330","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1529\/biophysj.106.091157","article-title":"Enhanced surfactant adsorption via polymer depletion forces: a simple model for reversing surfactant inhibition in acute respiratory distress syndrome","volume":"92","author":"Stenger","year":"2007","journal-title":"Biophys. J."},{"issue":"6","key":"10.1016\/j.biotechadv.2018.03.017_bb0335","doi-asserted-by":"crossref","first-page":"F497","DOI":"10.1136\/archdischild-2017-312722","article-title":"A first-in-human clinical study of a new SP-B and SP-C enriched synthetic surfactant (CHF5633) in preterm babies with respiratory distress syndrome","volume":"102","author":"Sweet","year":"2017","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"issue":"4","key":"10.1016\/j.biotechadv.2018.03.017_bb0340","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1164\/ajrccm.162.4.9909004","article-title":"Exogenous surfactant supplementation in infants with respiratory syncytial virus bronchiolitis","volume":"162","author":"Tibby","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.biotechadv.2018.03.017_bb0345","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jpeds.2013.04.053","article-title":"Comparative effectiveness of surfactant preparations in premature infants","volume":"163","author":"Trembath","year":"2013","journal-title":"J. Pediatr."},{"issue":"2","key":"10.1016\/j.biotechadv.2018.03.017_bb0350","doi-asserted-by":"crossref","DOI":"10.1542\/peds.103.2.e24","article-title":"Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30\u202fweeks' gestation","volume":"103","author":"Verder","year":"1999","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.biotechadv.2018.03.017_bb0355","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1159\/000326628","article-title":"Surfactant replacement therapy in developing countries","volume":"99","author":"Vidyasagar","year":"2011","journal-title":"Neonatology"},{"key":"10.1016\/j.biotechadv.2018.03.017_bb0360","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.403","article-title":"Aerosol delivery of synthetic lung surfactant","volume":"2","author":"Walther","year":"2014","journal-title":"PeerJ"},{"issue":"7","key":"10.1016\/j.biotechadv.2018.03.017_bb0365","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1164\/ajrccm.181.7.762","article-title":"Surfactant composition and biophysical properties are important in clinical studies","volume":"181","author":"Willson","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.biotechadv.2018.03.017_bb0370","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/00003246-199901000-00050","article-title":"Instillation of calf lung surfactant extract (calfactant) is beneficial in pediatric acute hypoxemic respiratory failure","volume":"27","author":"Willson","year":"1999","journal-title":"Crit. Care Med."},{"issue":"4","key":"10.1016\/j.biotechadv.2018.03.017_bb0375","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1001\/jama.293.4.470","article-title":"Effect of exogenous surfactant (calfactant) in pediatric acute lung injury: a randomized controlled trial","volume":"293","author":"Willson","year":"2005","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.biotechadv.2018.03.017_bb0380","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1378\/chest.14-1139","article-title":"The adult Calfactant in acute respiratory distress syndrome trial","volume":"148","author":"Willson","year":"2015","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.biotechadv.2018.03.017_bb0385","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2165\/00003495-199448030-00006","article-title":"Porcine-derived lung surfactant","volume":"48","author":"Wiseman","year":"1994","journal-title":"Drugs"},{"issue":"7","key":"10.1016\/j.biotechadv.2018.03.017_bb0390","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/j.bbamem.2011.03.006","article-title":"Comparative study of clinical pulmonary surfactants using atomic force microscopy","volume":"1808","author":"Zhang","year":"2011","journal-title":"Biochim. Biophys. Acta"}],"container-title":["Biotechnology Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0734975018300685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0734975018300685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T11:43:22Z","timestamp":1760010202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0734975018300685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":78,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0734975018300685"],"URL":"https:\/\/doi.org\/10.1016\/j.biotechadv.2018.03.017","relation":{},"ISSN":["0734-9750"],"issn-type":[{"value":"0734-9750","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical, technological, and economic issues associated with developing new lung surfactant therapeutics","name":"articletitle","label":"Article Title"},{"value":"Biotechnology Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biotechadv.2018.03.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}